Skip to main content
. 2019 Jul 26;57(8):e00319-19. doi: 10.1128/JCM.00319-19

TABLE 2.

Distribution of MICs for Enterococcus faecalis (n = 41) isolated from Australian meat chickens to 14 antimicrobialsa

Antimicrobial % of isolates with MIC (mg/liter)
% non-wild type (95% CI) Clinically resistant (%)
0.25 0.5 1 2 4 8 16 32 64 128 256 512 1,024
Ampicillin 0 2.4 14.6 2.4 61 | 9.8 9.8 0 0 0 0 0 0 19.5 (8.8–34.9) 9.8
Chloramphenicol 0 0 0 2.4 2.4 78 17.1 0 0 0 0 0 0 0.0 (0.0–8.6) 0
Daptomycin 12.2 4.9 12.2 34.1 24.4 | 12.2 0 0 0 0 0 0 0 12.2 (4.1–26.2)
Erythromycin 48.8 2.4 17.1 4.9 0 | 0 26.8 0 0 0 0 0 0 26.8 (14.2–42.9) 26.8
Gentamicin* 0 0 0 0 0 0 0 0 0 100 0 0 0 0
Kanamycin* 0 0 0 0 0 0 0 0 0 87.8 12.2 0 0 0
Lincomycin* 0 0 4.9 0 0 4.9 90.2 0 0 0 0 0 0
Linezolid 0 2.4 0 65.9 29.3 | 0 2.4 0 0 0 0 0 0 2.4 (0.1–12.9) 2.4
Penicillin(benzyl) 22 2.4 12.2 9.8 34.1 7.3 2.4 | 9.8 0 0 0 0 0 9.8 (2.7–23.1) 12.2
Quinupristin-dalfopristin* 0 7.3 0 34.1 9.8 22 19.5 7.3 0 0 0 0 0
Teicoplanin 87.8 9.8 0 0 | 0 0 0 0 0 2.4 0 0 0 2.4 (0.1–12.9) 2.4
Tetracycline 0 0 51.2 0 2.4 | 0 0 7.3 39 0 0 0 0 46.3 (30.7–62.6) 46.3
Vancomycin 7.3 43.9 31.7 12.2 2.4 | 2.4 0 0 0 0 0 0 0 2.4 (0.1–12.9) 0
Virginiamycin 0 0 2.4 17.1 48.8 17.1 7.3 2.4 | 0 4.9 0 0 0 4.9 (0.6–16.5)
a

Note E. faecalis is intrinsically resistant to lincomycin and quinupristin-dalfopristin. The percentages of isolates classified as non-wild type with the corresponding 95% CI and the percentages classified as clinically resistant are shown. For each drug, vertical bars show the positions of the ECOFF values, and shaded areas indicate the ranges of dilutions evaluated. ECOFF values are not presently available for antimicrobials denoted by an asterisk (*), and blank boxes in the table also indicate a lack of relevant breakpoints.